Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-21-101402
Filing Date
2021-03-31
Accepted
2021-03-31 07:51:00
Documents
71
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d30125d10k.htm   iXBRL 10-K 1926789
2 EX-4.20 d30125dex420.htm EX-4.20 13312
3 EX-21.1 d30125dex211.htm EX-21.1 2254
4 EX-23.1 d30125dex231.htm EX-23.1 2957
5 EX-31.1 d30125dex311.htm EX-31.1 10959
6 EX-31.2 d30125dex312.htm EX-31.2 10981
7 EX-32.1 d30125dex321.htm EX-32.1 4434
8 EX-32.2 d30125dex322.htm EX-32.2 4463
  Complete submission text file 0001193125-21-101402.txt   7379909

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA galt-20201231.xsd EX-101.SCH 61256
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE galt-20201231_cal.xml EX-101.CAL 28702
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE galt-20201231_def.xml EX-101.DEF 400817
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE galt-20201231_lab.xml EX-101.LAB 487734
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE galt-20201231_pre.xml EX-101.PRE 437964
14 EXTRACTED XBRL INSTANCE DOCUMENT d30125d10k_htm.xml XML 913871
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

EIN.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-31791 | Film No.: 21789854
SIC: 2834 Pharmaceutical Preparations